Autosomal dominant alzheimer's disease with early frontal lobe involvement associated with the Met239Ile mutation of presenilin 2 gene

Silvia Testi, Gian Maria Fabrizi, Sara Pompanin, Annachiara Cagnin

Research output: Contribution to journalArticlepeer-review

Abstract

Mutations in the Presenilin 2 gene (PSEN2) represent the less frequent genetic cause of familial Alzheimer's disease (FAD). Only eight PSEN2 mutations, reported in approximately 27 families, satisfied strict criteria of pathogenicity. We reported a patient with early-onset FAD and the PSEN2 p.Met239Ile mutation, presenting with severe executive dysfunction and myoclonic tremor, associated with memory loss. Brain SPECT study showed an early hypoperfusion of the frontal cortex. We confirmed the pathogenicity of PSEN2 p.Met239Ile mutation and its heterogeneous phenotypic expression. The modulating effect of the Apolipoprotein E and Prion Protein gene polymorphisms on the phenotypic variability was not confirmed.

Original languageEnglish
Pages (from-to)7-11
Number of pages5
JournalJournal of Alzheimer's Disease
Volume31
Issue number1
DOIs
Publication statusPublished - 2012

Keywords

  • Alzheimer's disease
  • familial
  • frontal lobe
  • mutation
  • Presenilin 2

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Fingerprint Dive into the research topics of 'Autosomal dominant alzheimer's disease with early frontal lobe involvement associated with the Met239Ile mutation of presenilin 2 gene'. Together they form a unique fingerprint.

Cite this